Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMXB-A and Risperidone in Schizophrenia
NCT02538081Phase 2Withdrawn
- Sponsor
- VA Office of Research & Development
- Start
- Aug 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dmxb-a in schizophrenia, sponsored by VA Office of Research & Development. Planned start Aug 2015; status: withdrawn.
02
Drugs
dmxb-a
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02538081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02538081.